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2) This selective cholinergic neurodegeneration is the basis of a cholinergic hypothesis, which triggered research efforts aimed at restoring the defective cholinergic transmission.
We have been studying the cognition activators in order to develop a new medicine for AD, and recently found a new compound, N- [2-(1-azabicyclo[3.3.0 
]octan-5-yl)ethyl]-2-ni-
troaniline fumarate (SK-946), which is highly efficacious and functionally selective for muscarinic M 1 affinity.
1)
In a recent pharmacokinetic study of SK-946 on rats and dogs, it was found that 4-position of the aniline ring is hydroxylated easily. 3) In addition, SK-946 displayed comparable affinities for cortical muscarinic M 1 receptors using either N-methylscopolamine (NMS) or oxotremorine-M (OXO-M) as radioligands. 4) Therefore, the goal of this study was to prepare compounds that have greater metabolic stability and agonistic property for muscarinic M1 receptor than SK-946.
Naturally occurring muscarinic M 1 agonist arecoline has high activity in vitro. There are, however, major drawbacks associated with this compound including low clinical efficacy and poor metabolic stability. 5) Many structural modifications have been made of arecoline to improve its pharmacological and pharmacokinetic properties towards a clinically more useful profile. One strategy most pursued for improving the pharmacological profile has been the replacement of the ester group with bioisosteric five-membered heterocyclic rings. 6) Some of the achievements were the 1,2,4-oxadiazoles as L-658903, 7) the 1,2,5-thiadiazoles as xanomeline 8) and tetrazole rings. 9) These modifications give high efficacy to the agonistic property at M 1 receptor and provide more stability than arecoline (Chart 1).
We have been studying the muscarinic activity of heterocycle derivatives based on the above. In this paper, we describe the synthesis and biological evaluation of heterocycles, as 1,2,4-oxadiazole, 1,2,5-thiadiazole and tetrazole derivatives, with the (1-azabicyclo [3.3.0] octan-5-yl)methyl moiety. The abilities of these compounds to improve cognitive function were assessed by radioligand binding assay using rats and passive avoidance tests in scopolamine-treated mice.
Chemistry
The five-membered azaheterocycles with the 1-azabicyclo [3.3.0] octanyl methyl group for biological tests were prepared as shown in Chart 2. The 1,2,4-oxadiazole ring was constructed from an ester and an oxime according to the method of Saunders et al. 7a) Compounds 2a and 2b were prepared by condensation of methyl (1-azabicyclo [3.3 .0]octan-5-yl)acetate (1) 10) with MeC(ϭNOH)NH 2 and H 2 NC(ϭNOH)-NH 2 , respectively.
Reaction of 5-chloromethyl-1-azabicyclo[3.3.0] octane hydrochloride (3) 10) with 5-methyltetrazole gave the tetrazole derivatives as a mixture of positional isomers 4a and 4b. Each isomer was obtained by chromatographic separation and its regiochemistry was spectroscopically assigned by the long-range H-C correlation spectroscopy (COSY) technique of NMR experiments.
(1-Azabicyclo[3.3.0]octan-5-yl)acetaldehyde (5) was prepared from corresponding cyano compound 10) by reduction with LiAl(OEt) 2 H 2 . Reaction of the aldehyde 5 with acetone cyanohydrine and NH 3 in MeOH gave aminonitrile 6, which was cyclized with sulfur monochloride to afford 3-chloro-4-(1-azabicyclo[3.3 .0]octan-5-yl)methyl-1,2,5-thiadiazole (7) according to the method of Sauerberg et al. 8a) Chloride 7 was treated with an appropriate sodium alkoxide to give the alkoxy compounds 8a and 8b.
Pharmacological Results and Discussion
The affinities of the present compounds for the M 1 and M 2 receptors were evaluated in terms of the abilities to displace [ 3 H]pirenzepine, an M 1 -selective ligand, from rat cerebral cortex membrane and [ 3 H]quinuclidinyl benzilate (QNB) from rat cerebellum membrane, respectively, and were evaluated in vivo for behavioral efficacy to scopolamine-treated dementia models.
Initially, the affinity for muscarinic M 1 and M 2 receptors of 1,2,4-oxadiazole derivatives was examined (Table 1) Hokusei-cho, Inabe-gun, Mie 511-0406, Japan. Received December 2, 1998; accepted March 19, 1999 In Studies by Showell and coworkers indicated that the potency of affinities for muscarinic M 1 receptor (by displacement of [ 3 H]N-methylscopolamine) of 3-amino and 3-methyl-1,2,4-oxadiazole derivatives having tetrahydropyridine were almost equal.
7)
Wadsworth and coworkers reported that the affinities of tetrazole derivatives with quinuclidine for muscarinic M 1 receptor were strong, but not as active as 1,2,4-oxadiazole derivatives (by displacement of [ 3 H]oxotremorine-M). 9) In our study, the affinity for muscarinic M 1 receptor of tetrazole derivatives 4a and 4b was as active as 1,2,4-oxadiazole derivatives 2a and 2b (Table 1) .
The affinity for muscarinic M 1 receptor of 1,2,5-thiadiazole derivatives 8a and 8b with 1-azabicyclo[3.3.0]octane moiety was examined (Table 1) . Studies by Sauerberg and coworkers showed that the affinities for muscarinic M 1 receptor of 3-n-pentyloxy-1,2,5-thiadiazole derivative having tetrahydropyridine were about ten times as active as the 3-ethoxy derivative (by displacement of [ 3 H]pirenzepine). 8) In 1-azabicyclo [3.3.0] octane derivatives, compound 8b (3-ethoxy derivative) had stronger affinity for M 1 receptor than 8a (3-n-pentyloxy Table 2 ).
In conclusion, our aromatic heterocycles having the characteristic cyclic amine, 1-azabicyclo [3.3.0] octane ring, had strong activity to muscarinic M 1 receptor. Although this affinity to the receptor of 2b was weaker than that of SK-946 in vitro, 2b was about 10 times as active as SK-946 in passive avoidance tasks in vivo. This was thought to result from the fact shown below. 1,2,4-Oxadiazole ring of 2b is more metabolically stable than aniline ring of SK-946, and, muscarinic M 1 agonistic property of 2b (QNB(IC 50 )/OXO-M(IC 50 ) ratio equal to 15) is higher than that of SK-946. 11) Previous reports by our group have found that SK-946 has other activity in addition to muscarinic M 1 agonistic property: it increases acetylcholine release in relatively low concentrations.
4) It is possible that compound 2b and other heterocyclic derivatives also have acetylcholine releasing activity.
Experimental
All melting points were determined on a Yanagimoto micromelting point apparatus and are uncorrected.
1 H-NMR spectra were taken at 60 MHz with a JEOL JNM-60 spectrometer, or at 270 MHz with a JEOL JNM-GSX270 spectrometer. Chemical shifts are expressed in d (ppm) values with tetramethylsilane as an internal standard and the following abbreviations are used: sϭsinglet, dϭdoublet, tϭtriplet, qϭquartet, mϭmultiplet, brϭbroad, ddϭ double doublet and dtϭdouble triplet. Mass spectra (MS) were recorded on a JEOL JMS-DX300, or on a JEOL JMS-SX102. Infrared (IR) spectra were taken with JASCO IR-810, or Perkin-Elmer 1600. Elemental analyses were performed by Yanagimoto MT-5.
5-(1-Azabicyclo[3.3.0]octan-5-yl)methyl-3-methyl-1,2,4-oxadiazole (2a)
Acetamide oxime (2.42 g, 32.7 mmol) suspended in tetrahydrofuran (THF) (75.0 ml) was heated to 60°C with NaH (980 mg of a 60% dispersion in oil, 32.7 mmol) for 1 h in the presence of 4A molecular sieves (5.00 g). Compound 1 (5.00 g, 27.3 mmol) in THF (25.0 ml) was added and the reaction mixture was heated under reflux for 2 h. After cooling, the reaction mixture was filtered and the solvent was removed in vacuo. Brine (20 ml) was added to the residue, which was extracted with CHCl 3 (10 mlϫ3 O: C, 63.74; H, 8.27; N, 20.27. Found: C, 63.58; H, 8.16; N, 20.37. 3-Amino-5-(1-azabicyclo[3.3.0]octan-5-yl)methyl-1,2,4-oxadiazole (2b) Sodium metal (1.26 g, 54.8 mmol) was added to absolute EtOH (50 ml) stirred in the presence of 4A molecular sieves (12.0 g). After 15 min at room temperature, hydroxyguanidine hemisulfate hemihydrate (4.36 g, 32.8 mmol) was added and the stirring was continued for another hour. Compound 1 (1.00 g, 5.46 mmol) was added to the mixture, which was then heated under reflux for 2 h. After cooling, the reaction mixture was filtered and the solvent was removed in vacuo. Water (40 ml) was added to the residue, which had been extracted with CH 2 Cl 2 (50 mlϫ4 O: C, 57.67; H, 7.74; N, 26.90. Found: C, 57.43; H, 7.46; N, 26.98 (5) (1.50 g, 4.52 mmol, 54% purity) in MeOH (5.0 ml) were added dropwise 10.3% NH 3 -MeOH (10.0 ml) and acetone cyanohydrine (1.38 g, 16.2 mmol). The reaction mixture was stirred under NH 3 gas atmosphere at room temperature for 2 d, and evaporated in vacuo to give 2.03 g (76.9%, 31% purity by intensity of methylene proton of 1 H-NMR) of crude cyanohydrine derivative 6 as a yellow oil.
To a solution of sulfur monochloride (2.71 g, 18.1 mmol) in DMF (8.0 ml) was added over 15 min a solution of the crude 6 (2.03 g, 4.52 mmol) in DMF (3.0 ml) at 2-4°C. The reaction mixture was stirred for an additional 2 h at 2-4°C, and poured into ice water (50 ml). After filtration, the filtrate was alkalized with NaHCO 3 and extracted with CH 2 Cl 2 . The extracts were dried and concentrated in vacuo to give 2.60 g (30.8%, purity 26%) of 7. The intermediate 7 was used without further purification.
1 H-NMR (CDCl 3 ) d: 1. m, 3, 2.61 (2H, dt, Jϭ10, 6 Hz, 2-CH 2 -pyrrolidine), 2.96 (2H, s, CH 2 ), 3.13 (2H, dt, Jϭ10, 6 Hz, . CIMS m/z: 244 (Mϩ1) ϩ , 110 (base peak). 3-(1-Azabicyclo[3.3.0]octan-5-yl)methyl-4-pentoxy-1,2,5-thiadiazole (8a) A solution of compound 7 (1.30 g, 2.30 mmol) in pentanol (2.0 ml) was added to a solution of sodium pentoxide in pentanol prepared from sodium (350 mg, 15.2 mmol) and pentanol (12.0 ml). The reaction mixture was stirred at 50°C for 2 h, then poured into ice-water (40 ml), and extracted with AcOEt (70 ml). The extracts were dried and evaporated in vacuo. Reference Compounds (Ϯ)-YM-796 was synthesized at our laboratory as fumarate salt.
12)
Passive Avoidance Performance in Scopolamine-Treated Mice A passive avoidance learning test using mice was carried out according to the previously reported method.
1b)
